Literature DB >> 19708989

Dinucleoside polyphosphates and uremia.

Vera Jankowski1, Thomas Günthner, Stefan Herget-Rosenthal, Walter Zidek, Joachim Jankowski.   

Abstract

Dinucleoside polyphosphates constitute a group of endogenous vasoregulatory purines and pyrimidines with a strong impact on physiologic and pathophysiologic processes of the cardiovascular system. Recently, the importance of dinucleoside polyphosphates in chronic kidney disease (CKD) and uremia gained increasing interest. Although our knowledge about the impact of dinucleoside polyphosphates in CKD and uremia is just at the beginning, this article reviews the current knowledge of the physiologic and pathophysiologic role of dinucleoside polyphosphates in CKD and uremia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19708989     DOI: 10.1111/j.1525-139X.2009.00588.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  4 in total

Review 1.  Purinergic signalling in the kidney in health and disease.

Authors:  Geoffrey Burnstock; Louise C Evans; Matthew A Bailey
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

2.  Indoxyl sulfate decreases uridine adenosine tetraphosphate-induced contraction in rat renal artery.

Authors:  Takayuki Matsumoto; Natsume Taguchi; Keisuke Ozawa; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Pflugers Arch       Date:  2022-10-01       Impact factor: 4.458

3.  The enzymatic activity of the VEGFR2 receptor for the biosynthesis of dinucleoside polyphosphates.

Authors:  Vera Jankowski; Anna Schulz; Axel Kretschmer; Harald Mischak; Falko Boehringer; Markus van der Giet; Doreen Janke; Mirjam Schuchardt; Ralf Herwig; Walter Zidek; Joachim Jankowski
Journal:  J Mol Med (Berl)       Date:  2013-05-01       Impact factor: 4.599

4.  Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y12 Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial.

Authors:  Francesco Franchi; Stefan K James; Tatevik Ghukasyan Lakic; Andrzej J Budaj; Jan H Cornel; Hugo A Katus; Matyas Keltai; Frederic Kontny; Basil S Lewis; Robert F Storey; Anders Himmelmann; Lars Wallentin; Dominick J Angiolillo
Journal:  J Am Heart Assoc       Date:  2019-03-19       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.